6,7-seco-ent-kauranoids derived from oridonin as potential anticancer agents

Xu, Shengtao, Yao, Hong, Hu, Mei, Li, Dahong, Zhu, Zheying, Xie, Weijia, Yao, Hequan, Wu, Liang, Chen, Zhe-Sheng and Xu, Jinyi (2017) 6,7-seco-ent-kauranoids derived from oridonin as potential anticancer agents. Journal of Natural Products . ISSN 1520-6025

Full text not available from this repository.


Structurally unique 6,7-seco-ent-kaurenes, which are widely distributed in the genus Isodon, have attracted considerable attention because of their antitumor activities. Previously, a convenient conversion of commercially available oridonin (1) to 6,7-seco-ent-kaurenes was developed. Herein, several novel spiro-lactone-type ent-kaurene derivatives bearing various substituents at the C-1 and C-14 positions were further designed and synthesized from the natural product oridonin. Moreover, a number of seven-membered C-ring-expanded 6,7-seco-ent-kaurenes were also identified for the first time. It was observed that most of the spiro-lactone-type ent-kaurenes tested markedly inhibited the proliferation of cancer cells, with an IC50 value as low as 0.55 μM. An investigation on its mechanism of action showed that the representative compound 7b affected the cell cycle and induced apoptosis at a low micromolar level in MCF-7 human breast cancer cells. Furthermore, compound 7b inhibited liver tumor growth in an in vivo mouse model and exhibited no observable toxic effects. Collectively, the results warrant further preclinical investigations of these spiro-lactone-type ent-kaurenes as potential novel anticancer agents.

Item Type: Article
RIS ID: https://nottingham-repository.worktribe.com/output/882385
Schools/Departments: University of Nottingham, UK > Faculty of Science > School of Pharmacy
Identification Number: https://doi.org/10.1021/acs.jnatprod.7b00057
Depositing User: Zhu, Zheying
Date Deposited: 18 Sep 2017 08:13
Last Modified: 04 May 2020 19:06
URI: https://eprints.nottingham.ac.uk/id/eprint/46459

Actions (Archive Staff Only)

Edit View Edit View